Table 1.

COVID-19 cases, its mortality, and the incidence of selective IgA deficiency in various countries

Countries	Population (M)	Cases of COVID-19	Deaths caused by COVID-19	Cases of COVID-19/1M	Deaths caused by COVID-19/1M	Mortality (deaths/cases) ×100	IgA deficiency (%)
Australia	25.20	7,288	102	289.2	4.0	1.3996	0.230
Austria	8.95	17,034	674	1,903.2	75.3	3.9568	0.260
Brazil	211.05	802,828	40,919	3,804.0	193.9	5.0969	0.100
Canada	37.41	99,159	8,071	2,650.6	215.7	8.1395	0.180
China	1,433.78	84,216	4,638	58.7	3.2	5.5073	0.024
Czechia	10.69	9,855	328	921.9	30.7	3.3283	0.240
Finland	5.50	7,064	325	1,284.4	59.1	4.6008	0.080
France	65.13	192,493	29,349	2,955.5	450.6	15.2468	0.030
Germany	83.52	186,691	8,772	2,235.3	105.0	4.6987	1.260
Icelans	0.34	1,807	10	5,314.7	29.4	0.5534	0.160
Iran	83.91	180,156	8,584	2,147.0	102.3	4.7648	0.150
Japan	126.86	17,187	922	135.5	7.3	5.3645	0.007
Nigeria	200.96	14,554	387	72.4	1.9	2.6591	0.160
Norway	5.38	8,608	242	1,600.0	45.0	2.8113	0.080
Sauji Arabia	34.27	116,021	857	3,385.5	25.0	0.7387	0.700
Spain	46.74	242,707	27,136	5,192.7	580.6	11.1806	0.610
Turkey	83.43	174,023	4,763	2,085.9	57.1	2.7370	0.520
UK	67.53	292,860	41,364	4,336.7	612.5	14.1242	0.110
USA	329.06	2,023,385	113,818	6,149.0	345.9	5.6251	0.300

M, million.